Clinical trial · Interventional
Evaluation of an Interventional Module to Assist Physicians Introducing ACP to Cancer Patients
National Taiwan University Hospital,Taiwan (R.O.C)
NCT04969952CI-TRIAL-00078055completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of an Interventional module to assist physicians introducing ACP to cancer patients
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Patients | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| For interventional module | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group A
- description
- Group A had watching educational module plus ACP brochure
- interventionNames
- Other: For interventional module
- type
- ACTIVE_COMPARATOR
- label
- Group B
- description
- Group B ACP brochure only
- interventionNames
- Other: For interventional module
Primary outcomes (1)
- measure
- Sign DNR (Do-Not-Resuscitate)
- timeFrame
- 3 month
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 85 Years
Show eligibility criteria text
"Inclusion Criteria" and "Exclusion Criteria" Inclusion Criteria 1. Older than 20-years-old 2. Diagnosed with cancer 3. Have not signed any form of AD or DNR Exclusion Criteria 1. Under 20-years-old 2. Can not speak or listen, difficult communication 3. Signed AD or DNR
References
Publications (0)
Data not yet available
No reference posted for this study.